DAVID M MOTT Insider Trading $EPZM Epizyme, Inc.
Get free email notifications about insider trading for DAVID M MOTT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID M MOTT. DAVID M MOTT is 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in Workday, Inc. ($WDAY) and 10% Owner in AEROHIVE NETWORKS, INC ($HIVE) and 10% Owner in BOX INC ($BOX) and 10% Owner in Millennial Media Inc. ($MM) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Care.com Inc ($CRCM) and 10% Owner in Clovis Oncology, Inc. ($CLVS) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Omthera Pharmaceuticals, Inc. ($OMTH) and Director in TESARO, Inc. ($TSRO) and 10% Owner in CVENT INC ($CVT) and 10% Owner in Dermira, Inc. ($DERM) and Director in Epizyme, Inc. ($EPZM) and 10% Owner in Loxo Oncology, Inc. ($LOXO).
DAVID M MOTT in Epizyme, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: Director
Holdings: 651 shares
Current Value: $7,845
Latest Transaction: Aug 18 2014
$EPZM Market Capitalization: $707.73M
$EPZM Previous Close: $12.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID M MOTT in Epizyme, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, HIVE, BOX, CRCM, CLVS, CVT, DERM, EPZM, ILIU, LOXO, MM, OMTH, ROKA, TSRO, TCON, WDAY
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18 2014 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 651 | 0 | 651 | 0 to 651 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Jul 28 2014 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | A | 33.21 | 7,333 | 243,529 | 7,333 | |
| Nov 18 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 19.31 | 25,800 | 498,185 | 406,500 | 380.7 K to 406.5 K (+6.78 %) |
| Nov 18 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 20.31 | 23,700 | 481,269 | 380,700 | 357 K to 380.7 K (+6.64 %) |
| Nov 18 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 19.04 | 163,620 | 3,115,538 | 357,000 | 193.4 K to 357 K (+84.61 %) |
| Nov 18 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 19.99 | 152,459 | 3,047,335 | 193,380 | 40.9 K to 193.4 K (+372.57 %) |
| Nov 18 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 20.91 | 40,921 | 855,654 | 40,921 | 0 to 40.9 K |
| Jun 07 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | A | 25.73 | 17,666 | 454,546 | 17,666 | |
| Jun 07 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | C | 0.00 | 16,899,721 | 0 | 0 | |
| Jun 07 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 15.00 | 400,000 | 6,000,000 | 6,033,240 | 5.6 M to 6 M (+7.10 %) |
| Jun 07 2013 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | C | 0.00 | 5,633,240 | 0 | 5,633,240 | 0 to 5.6 M |
Page: 1